サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1131715

光免疫療法の世界市場、治療領域別・エンドユーザー別・地域別：競合・予測・機会 (2027年)

Global Photoimmunotherapy Market By Therapeutic Area, By End User, and By Region, Competition Forecast and Opportunities, 2027
出版日: | 発行: TechSci Research | ページ情報: 英文 118 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

光免疫療法の世界市場、治療領域別・エンドユーザー別・地域別：競合・予測・機会 (2027年)
出版日: 2022年10月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の光免疫療法市場は、予測期間中 (2023年～2027年) に強固なCAGRを示すと予想されています。

世界のがん罹患率の増加、医療費の増大、新規がん治療法発見のための研究開発 (R&D) 活動の進行などの要因が、市場需要を牽引しています。また、医療インフラ整備や熟練した医療従事者の雇用のための主要機関による投資の増加、政府の有利な償還政策は、今後5年間の光免疫療法の世界市場の成長を加速させることができる他の顕著な要因となっています。

当レポートでは、世界の光免疫療法の市場について分析し、全体的な市場規模の動向見通しや市場シェア構造 (治療領域別・エンドユーザー別)、地域別・主要国の詳細動向、主な市場促進・抑制要因、企業間の市場競争構造、主要企業のプロファイル、今後の市場成長の方向性などを調査しております。

目次

第1章 製品概要

第2章 分析方法

第3章 エグゼクティブサマリー

第4章 世界の光免疫療法市場に対するCOVID-19の影響

第5章 顧客側の見解

  • セラピーの意識
  • がんの有病率：男女別
  • がんの有病率：年齢層別
  • がんの有病率：地域別

第6章 治験分析

第7章 特許分析

第8章 世界の光免疫療法市場：将来展望

  • 市場規模とその予測
    • 金額ベース
  • 市場シェアとその予測
    • 治療領域別 (頭頸部がん、転移性黒色腫、その他)
    • エンドユーザー別 (病院・診療所、外来治療センター、バイオテクノロジー・製薬会社、その他)
    • 企業別 (2021年)
    • 地域別
  • 製品市場マップ

第9章 北米の光免疫療法市場の見通し

  • 市場規模とその予測
  • 市場シェアと予測
    • 治療領域別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国の光免疫療法市場の見通し
    • メキシコの光免疫療法市場の見通し
    • カナダの光免疫療法市場の見通し

第10章 欧州の光免疫療法市場の見通し

  • 市場規模とその予測
  • 市場シェアと予測
  • 欧州：国別分析
    • フランスの光免疫療法市場の見通し
    • ドイツの光免疫療法市場の見通し
    • 英国の光免疫療法市場の見通し
    • イタリアの光免疫療法市場の見通し
    • スペインの光免疫療法市場の見通し

第11章 アジア太平洋の光免疫療法市場の見通し

  • 市場規模とその予測
  • 市場シェアと予測
  • アジア太平洋：国別分析
    • 中国の光免疫療法市場の見通し
    • インドの光免疫療法市場の見通し
    • 韓国の光免疫療法市場の見通し
    • 日本の光免疫療法市場の見通し
    • オーストラリアの光免疫療法市場の見通し

第12章 南米の光免疫療法市場の見通し

  • 市場規模とその予測
  • 市場シェアと予測
  • 南米：国別分析
    • ブラジルの光免疫療法市場の見通し
    • アルゼンチンの光免疫療法市場の見通し
    • コロンビアの光免疫療法市場の見通し

第13章 中東・アフリカの光免疫療法市場の見通し

  • 市場規模とその予測
  • 市場シェアと予測
  • 中東・アフリカ：国別分析
    • 南アフリカの光免疫療法市場の見通し
    • サウジアラビアの光免疫療法市場の見通し
    • アラブ首長国連邦の光免疫療法市場の見通し

第14章 市場力学

  • 促進要因
  • 課題

第15章 市場の傾向と動静

第16章 競合情勢

  • Rakuten Medical, Inc.
  • Shimadzu Corporation
  • Modulight Corporation
  • Steba Biotech Ltd.
  • Luzitin SA

第17章 戦略的提言

目次
Product Code: 12819

The global photoimmunotherapy market is anticipated to witness robust CAGR in the forecast period, 2023-2027. Factors such as the increasing prevalence of cancer worldwide, growing healthcare expenditure, and ongoing research and development activities to find novel cancer treatment therapies primarily drive the demand for the global photoimmunotherapy market. The rise in the investments by the leading authorities to develop the healthcare infrastructure and hire skilled healthcare professionals and favorable government reimbursement policies are the other prominent factors that can accelerate the global photoimmunotherapy market growth over the next five years.

Increased Cancer Prevalence Worldwide Drives the Market Growth

Cancer is a major health concern and is a leading cause of death across the globe. According to World Health Organization, cancer accounted for nearly 10 million deaths in 2020. During cancer, there is the rapid creation of abnormal cells that grow beyond their usual boundaries and can invade the adjoining parts of the body and spread to other organs, and the process is called metastasis. Some of the most common kinds of cancer are breast, lung, colon, rectum, and prostate cancers. In 2020, due to lung cancer, around 1.0 million deaths were observed. Similarly, for colon and rectum and liver cancer, the number of deaths in 2020 was 916000 and 830000. Adoption of an unhealthy and sedentary lifestyle, high body mass index, high alcohol, and tobacco consumption, and low fruit and vegetable intake are the main cancer-causing factors. Approximately 400 000 children develop cancer every year, and cervical cancer is the most common cancer in 23 countries. Cancer can be reduced through early detection and the right treatment and care of the patients. The majority of cancers can be cured if detected and treated early. Photoimmunotherapy is the recently developed hybrid cancer therapy that directly kills cancer cells as well as produces a therapeutic host immune response. Conventional immunotherapies such as checkpoint inhibition, engineered T cells and suppressor cell depletion, and immune-activating cytokine therapy do not directly destroy the cancer cells and rely on activating the immune system. Photoimmunotherapy selectively destroys the cancer cells, which releases cancer antigens from dying cancer cells. Therefore, the increased cancer incidence worldwide and the high mortality rate due to cancer are expected to bolster the global photoimmunotherapy market growth over the forecast period.

Favorable Government Policies Supports the Market Growth

The government of various countries are concerned with the growing number of cancer cases and are taking steps to lower the patient mortality rate due to cancer. They are providing financial support, reimbursing the cost incurred during the cancer treatment procedures, and funding cancer treatment research and development activities, among others. For instance, in India, some of the steps taken by the government that can fund cancer treatment are Health Minister's Cancer Patient Fund, The Health Minister's Discretionary Grants, The Central Government Health Scheme (CGHS), National Health Protection Scheme and The Prime Minister's National Relief Fund. Leading authorities of various countries are also promoting the adoption of novel technologies to treat cancer effectively. Massive support from the governments is making the market players invest and find new solutions for cancer treatment. Therefore, supportive government policies and the entry of new market players are expected to play a major role in boosting the global photoimmunotherapy market growth over the next five years.

Market Segmentation

The global photoimmunotherapy market is segmented into therapeutic area, end user, regional distribution, and competitive landscape. Based on therapeutic area, the market is divided into head & neck cancer, metastatic melanoma, and others. Based on end user, the market is divided into hospitals & clinics, ambulatory care centers, biotechnology & pharmaceutical companies, and others. The market analysis also studies the regional segmentation, which is divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region. In terms of country, the United States is expected to hold a significant market share due to the early adoption of advanced technologies by the healthcare sector and the presence of major market players in the country.

Market Players

Rakuten Medical, Inc., Shimadzu Corporation, Modulight Corporation, Steba Biotech Ltd., Luzitin SA are the major market players operating in the global photoimmunotherapy market.

Report Scope:

In this report, global photoimmunotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Photoimmunotherapy Market, By Therapeutic Area:

  • Head & Neck Cancer
  • Metastatic Melanoma
  • Others

Photoimmunotherapy Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Biotechnology & Pharmaceutical Companies
  • Others

Photoimmunotherapy Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global photoimmunotherapy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Photoimmunotherapy Market

5. Voice of Customer

  • 5.1. Therapy Awareness
  • 5.2. Cancer Prevalence, By Gender
  • 5.3. Cancer Prevalence, By Age Group
  • 5.4. Cancer Prevalence, By Region

6. Clinical Trial Analysis

7. Patent Analysis

8. Global Photoimmunotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutic Area (Head & Neck Cancer, Metastatic Melanoma, Others)
    • 8.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Biotechnology & Pharmaceutical Companies, Others)
    • 8.2.3. By Company (2021)
    • 8.2.4. By Region
  • 8.3. Product Market Map

9. North America Photoimmunotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutic Area
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Photoimmunotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutic Area
        • 9.3.1.2.2. By End User
    • 9.3.2. Mexico Photoimmunotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutic Area
        • 9.3.2.2.2. By End User
    • 9.3.3. Canada Photoimmunotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutic Area
        • 9.3.3.2.2. By End User

10. Europe Photoimmunotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutic Area
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. Europe: Country Analysis
    • 10.3.1. France Photoimmunotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutic Area
        • 10.3.1.2.2. By End User
    • 10.3.2. Germany Photoimmunotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutic Area
        • 10.3.2.2.2. By End User
    • 10.3.3. United Kingdom Photoimmunotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutic Area
        • 10.3.3.2.2. By End User
    • 10.3.4. Italy Photoimmunotherapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Therapeutic Area
        • 10.3.4.2.2. By End User
    • 10.3.5. Spain Photoimmunotherapy Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Therapeutic Area
        • 10.3.5.2.2. By End User

11. Asia-Pacific Photoimmunotherapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapeutic Area
    • 11.2.2. By End User
    • 11.2.3. By Country
  • 11.3. Asia-Pacific: Country Analysis
    • 11.3.1. China Photoimmunotherapy Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapeutic Area
        • 11.3.1.2.2. By End User
    • 11.3.2. India Photoimmunotherapy Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapeutic Area
        • 11.3.2.2.2. By End User
    • 11.3.3. South Korea Photoimmunotherapy Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapeutic Area
        • 11.3.3.2.2. By End User
    • 11.3.4. Japan Photoimmunotherapy Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Therapeutic Area
        • 11.3.4.2.2. By End User
    • 11.3.5. Australia Photoimmunotherapy Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Therapeutic Area
        • 11.3.5.2.2. By End User

12. South America Photoimmunotherapy Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Therapeutic Area
    • 12.2.2. By End User
    • 12.2.3. By Country
  • 12.3. South America: Country Analysis
    • 12.3.1. Brazil Photoimmunotherapy Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Therapeutic Area
        • 12.3.1.2.2. By End User
    • 12.3.2. Argentina Photoimmunotherapy Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Therapeutic Area
        • 12.3.2.2.2. By End User
    • 12.3.3. Colombia Photoimmunotherapy Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Therapeutic Area
        • 12.3.3.2.2. By End User

13. Middle East and Africa Photoimmunotherapy Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Therapeutic Area
    • 13.2.2. By End User
    • 13.2.3. By Country
  • 13.3. MEA: Country Analysis
    • 13.3.1. South Africa Photoimmunotherapy Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Therapeutic Area
        • 13.3.1.2.2. By End User
    • 13.3.2. Saudi Arabia Photoimmunotherapy Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Therapeutic Area
        • 13.3.2.2.2. By End User
    • 13.3.3. UAE Photoimmunotherapy Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Therapeutic Area
        • 13.3.3.2.2. By End User

14. Market Dynamics

  • 14.1. Drivers
  • 14.2. Challenges

15. Market Trends & Developments

16. Competitive Landscape

  • 16.1. Rakuten Medical, Inc.
  • 16.2. Shimadzu Corporation
  • 16.3. Modulight Corporation
  • 16.4. Steba Biotech Ltd.
  • 16.5. Luzitin SA

17. Strategic Recommendations